Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Teleflex Inc.

Start price
Target price
Perf. (%)
€198.00
22.10.22
€210.00
22.10.23
-11.62%
23.10.23

melinda 
22.10.22 20%
sell
EssilorLuxottica SA

Start price
Target price
Perf. (%)
€155.45
23.10.22
€150.00
23.10.23
5.06%
21.10.23

melinda 
23.10.22 20%
buy
Thermo Fisher Scientific Inc.

Start price
Target price
Perf. (%)
€519.40
20.10.22
€530.00
20.10.23
-15.56%
21.10.23

melinda 
20.10.22 50%
buy
Incyte Corp.

Start price
Target price
Perf. (%)
€72.17
18.10.22
€76.00
18.10.23
-25.62%
19.10.23

melinda 
18.10.22 20%
buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€101.82
16.09.23
-
16.10.23
1.69%
17.10.23

fabudagga 
16.09.23 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€71.72
30.08.23
-
30.08.24
4.55%
16.10.23

fenjal 
30.08.23 50%
buy
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€32.22
11.10.23
-
11.10.24
0.74%
14.10.23

daimler1 
11.10.23 50%
sell
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€67.38
13.10.22
€46.00
13.10.23
9.44%
14.10.23

Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Snowman 
13.10.22 50%
buy
GSK plc

Start price
Target price
Perf. (%)
€15.62
13.10.22
€20.00
13.10.23
11.01%
14.10.23

High dividend yield expected
Good rating
Very small cyclical dependencies
Fair valuation
Snowman 
13.10.22 50%
sell
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€38.99
04.10.23
€22.00
04.10.24
-16.75%
14.10.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
kostojunior 
04.10.23 0%
buy
Sartorius Stedim Biotech S.A.

Start price
Target price
Perf. (%)
€226.00
30.09.23
-
30.09.24
-15.49%
14.10.23

KongVestor 
30.09.23 50%
sell
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€533.50
19.09.23
€558.00
19.09.24
6.56%
11.10.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
19.09.23 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€337.60
09.04.23
€362.00
09.10.23
57.73%
09.10.23

Monz 
09.04.23 50%
buy
Illumina Inc.

Start price
Target price
Perf. (%)
€219.65
06.10.22
-
06.10.23
-39.65%
06.10.23

Joe130978 
06.10.22 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€422.40
27.06.23
€800.00
31.01.29
20.50%
01.10.23

Could be very worthwhile Investment >20% year
BiotechBee 
27.06.23 80%
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€246.80
19.09.23
€250.00
19.09.24
4.13%
27.09.23

Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
Traumtanz 
19.09.23 50%
sell
Novartis AG ADR

Start price
Target price
Perf. (%)
€79.40
21.09.22
€70.00
21.09.23
20.40%
22.09.23

kaufmeister 
21.09.22 50%
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€228.00
20.09.22
€270.00
20.09.23
11.84%
21.09.23

maria3 
20.09.22 50%
buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€116.40
20.09.22
€125.00
20.09.23
8.29%
21.09.23

melinda 
20.09.22 50%
buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€103.36
19.09.22
€130.00
19.09.23
-8.59%
20.09.23

Could be worthwhile Investment >10% per year
High dividend yield expected
Revenue growth >5% per year expected
Top 10 in its market
gerihouse 
19.09.22 70%
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€247.05
26.12.22
€255.00
26.12.23
-0.10%
19.09.23

Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
Traumtanz 
26.12.22 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€555.50
15.09.23
€558.00
15.09.24
-3.96%
19.09.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
15.09.23 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€64.59
16.09.22
-
16.09.23
9.92%
16.09.23

Joe130978 
16.09.22 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€309.00
15.09.22
€550.00
15.09.23
74.76%
16.09.23

Ankica 
15.09.22 50%
sell
Coloplast A/S B

Start price
Target price
Perf. (%)
€104.50
02.09.23
-
02.09.24
-0.38%
16.09.23

KongVestor 
02.09.23 50%